Abstract
Background: Arterial stiffening is central to the vascular ageing process and a powerful predictor and cause of diverse vascular pathologies and mortality. We investigated age and sex trajectories, regional differences, and global reference values of arterial stiffness as assessed by pulse wave velocity (PWV). Methods: Measurements of brachial-ankle or carotid-femoral PWV (baPWV or cfPWV) in generally healthy participants published in three electronic databases between database inception and August 24th, 2020 were included, either as individual participant-level or summary data received from collaborators (n = 248,196) or by extraction from published reports (n = 274,629). Quality was appraised using the Joanna Briggs Instrument. Variation in PWV was estimated using mixed-effects meta-regression and Generalized Additive Models for Location, Scale, and Shape. Findings: The search yielded 8920 studies, and 167 studies with 509,743 participants from 34 countries were included. PWV depended on age, sex, and country. Global age-standardised means were 12.5 m/s (95% confidence interval: 12.1–12.8 m/s) for baPWV and 7.45 m/s (95% CI: 7.11–7.79 m/s) for cfPWV. Males had higher global levels than females of 0.77 m/s for baPWV (95% CI: 0.75–0.78 m/s) and 0.35 m/s for cfPWV (95% CI: 0.33–0.37 m/s), but sex differences in baPWV diminished with advancing age. Compared to Europe, baPWV was substantially higher in the Asian region (+1.83 m/s, P = 0.0014), whereas cfPWV was higher in the African region (+0.41 m/s, P < 0.0001) and differed more by country (highest in Poland, Russia, Iceland, France, and China; lowest in Spain, Belgium, Canada, Finland, and Argentina). High vs. other country income was associated with lower baPWV (−0.55 m/s, P = 0.048) and cfPWV (−0.41 m/s, P < 0.0001). Interpretation: China and other Asian countries featured high PWV, which by known associations with central blood pressure and pulse pressure may partly explain higher Asian risk for intracerebral haemorrhage and small vessel stroke. Reference values provided may facilitate use of PWV as a marker of vascular ageing, for prediction of vascular risk and death, and for designing future therapeutic interventions. Funding: This study was supported by the excellence initiative VASCage funded by the Austrian Research Promotion Agency, by the National Science Foundation of China, and the Science and Technology Planning Project of Hunan Province. Detailed funding information is provided as part of the Acknowledgments after the main text.
Original language | English |
---|---|
Article number | 104619 |
Journal | EBioMedicine |
Volume | 92 |
DOIs | |
Publication status | Published - Jun 2023 |
Keywords
- All-cause mortality
- Arterial stiffness
- Cardiovascular disease
- Hypertensive end-organ damage
- Prevention
- Pulse wave velocity
- Reference values
- Risk factors
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: EBioMedicine, Vol. 92, 104619, 06.2023.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Global distributions of age- and sex-related arterial stiffness
T2 - systematic review and meta-analysis of 167 studies with 509,743 participants
AU - Global Pulse Wave Velocity Study Group
AU - Lu, Yao
AU - Kiechl, Sophia J.
AU - Wang, Jie
AU - Xu, Qingbo
AU - Kiechl, Stefan
AU - Pechlaner, Raimund
AU - Aguilar, David
AU - Al-Hashmi, Khamis M.
AU - Alvim, Rafael O.
AU - Al-Zakwani, Ibrahim S.
AU - Antza, Christina
AU - Cicero, Arrigo F.G.
AU - Avramovska, Maja
AU - Avramovski, Petar
AU - Baek, Hyun Jae
AU - Bäck, Magnus
AU - Bailey, Kent
AU - Baldo, Marcelo P.
AU - Batista, Rosângela F.L.
AU - Benetos, Athanasios
AU - Benjamin, Emelia J.
AU - Bia, Daniel
AU - Borghi, Claudio
AU - Roux, Shani Botha Le
AU - Breet, Yolandi
AU - Burgner, David
AU - Cardoso, Viviane C.
AU - Cecelja, Marina
AU - Ceponiene, Indre
AU - Chen, Chen Huan
AU - Cheung, Michael
AU - Cheng, Hao min
AU - Cho, Jaegeol
AU - Chowienczyk, Phil
AU - Coelho, Eduardo B.
AU - Cseprekal, Orsolya
AU - Silva, Amilcar BT Da
AU - Dallaire, Frédéric
AU - Cunha, Roberto De Sá
AU - Diaz, Alejandro
AU - Ferreira, Albano V.L.
AU - Ferrières, Jean
AU - Furuta, Yoshihiko
AU - Gómez-Marcos, Manuel A.
AU - Gómez-Sánchez, Leticia
AU - Halcox, Julian
AU - Hanis, Craig
AU - Herzig, Karl Heinz
AU - Jaeggi, Edgar
AU - Kavousi, Maryam
N1 - Funding Information: This study was supported by the excellence initiative VASCage funded by the Austrian Research Promotion Agency, by the National Science Foundation of China, and the Science and Technology Planning Project of Hunan Province. Detailed funding information is provided as part of the Acknowledgments after the main text.Funding: This study was supported by the excellence initiative VASCage (Research Centre on Vascular Ageing and Stroke, project number 868624) of the Austrian Research Promotion Agency FFG (COMET program–Competence Centers for Excellent Technologies) funded by the Federal Ministry for Climate Protection, Environment, Energy, Transport, Innovation and Technology; the Federal Ministry for Labour and Economy; and the federal states Tyrol (via Standortagentur), Salzburg, and Vienna (via Vienna Business Agency); as well as by the National Science Foundation of China (81800393, 81870171, and 81570271) and the Science and Technology Planning Project of Hunan Province (2019RS2014). DPUK provided data access for this project through MRC grant ref MR/L023784/2” (core funding). This article uses unit record data from Growing Up in Australia, the Longitudinal Study of Australian Children (LSAC), conducted in partnership between the Department of Social Services, the Australian Institute of Family Studies, and the Australian Bureau of Statistics. The CheckPoint study was supported by the Australian National Health and Medical Research Council (NHMRC) Project Grants [1041352, 1109355]; the Royal Children's Hospital Foundation [2014-241]; the Murdoch Children's Research Institute; The University of Melbourne; the National Heart Foundation of Australia [100660]; Financial Markets Foundation for Children [2014-055, 2016-310]; and the Victorian Deaf Education Institute. Research at the Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. MW was supported by NHMRC Principal Research Fellowship 1160906. Sapaldia was funded by the Swiss National Science Foundation Grant Numbers 33-CS-30-177506; 33-CS-30-148470. The Framingham Heart Study is supported by: HHSN268201500001I; N01-HC 25195; 75N92019D00031; 1R01HL60040; 1RO1HL70100. †Members of the Global PWV Study Group, David Aguilar1, Khamis M Al-Hashmi2, Rafael O Alvim3, Ibrahim S Al-Zakwani2, Christina Antza4, Arrigo FG Cicero5,6, Maja Avramovska7, Petar Avramovski8,9, Hyun Jae Baek10, Magnus Bäck11,12, Kent Bailey13, Marcelo P Baldo14, Rosângela FL Batista15, Athanasios Benetos16,17, Emelia J Benjamin18–20, Daniel Bia21,22, Claudio Borghi5, Shani Botha-Le Roux23, Yolandi Breet23,24, David Burgner25–27, Viviane C Cardoso28, Marina Cecelja29, Indre Ceponiene30, Chen-Huan Chen31, Michael Cheung25,26,32, Hao-min Cheng33, Jaegeol Cho10, Phil Chowienczyk29, Eduardo B Coelho34, Orsolya Cseprekal35, Amilcar BT Da Silva36,37, Frédéric Dallaire38, Roberto De Sá Cunha39, Alejandro Diaz40, Albano VL Ferreira39, Jean Ferrières41,42, Yoshihiko Furuta43, Manuel A Gómez-Marcos44,45, Leticia Gómez-Sánchez44, Julian Halcox46, Craig Hanis47, Karl-Heinz Herzig48,49, Edgar Jaeggi50, Maryam Kavousi51, Ursula Kiechl-Kohlendorfer52, Hack-Lyoung Kim53, Mi-Kyung Kim54, Yu-Mi Kim54, Eva Kis55, Michael Knoflach56, Vasilios Kotsis4, Teruhide Koyama57, Michaela Kozakova58, Ruan Kruger23,24, Iftikhar J Kullo13, Sun-Seog Kweon59, Irene Lambrinoudaki60, Chang Liu61, Markus Loeffler62,63, Jeongok G Logan64, Jane Maddock65, Pedro Magalhães39, João Maldonado66, Francesco US Mattace-Raso67, Alex Messner68, Michelle L Meyer69, Jie Mi70, José Geraldo Mill71,72, Gary F Mitchell73, Jian-Jun Mu74, Iram F Muhammad75, Johannes Nairz68, Atsushi Nakagomi76,77, Mieko Nakamura59, Peter M Nilson75, Toshiharu Ninomiya43, Carlo Palombo78, Alexandre C Pereira79, Telmo Pereira80,81, Daniel P Capingana36, Anna K Poon82, Nicole Probst-Hensch83,84, Arshed A Quyyumi85, George S Reusz86, Moo-Yong Rhee87,88, Cecilia CC Ribeiro15, Ernst Rietzschel89, Paulo RH Rocha28, Enrique Rodilla90, Marta Rojek91, Jean-Bernard Ruidavets42, Joost HW Rutten92, Yasuaki Saijo93, Paolo Salvi94, Arno Schmidt-Trucksäss95, Markus Scholz62,63, Min-Ho Shin96, Patrick Segers97, Kimon Stamatelopoulos98, Irina D Strazhesko99, Minoru Sugiura100, Olga N Tkacheva99, Hirofumi Tomiyama101, Elaine M Urbina102, Inge CL van den Munckhof92, Ramachandran S Vasan103,104, Melissa A Wake25,26, Goya Wannamethee105, Andrew Wong65, Akira Yamashina101, Yinkun Yan70, Divanei Zaniqueli71, Fang Zhu50, Yanina Zócalo22. 1 LSU Health New Orleans School of Medicine, New Orleans, USA. 2 College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman. 3 Department of Physiological Sciences, Federal University of Amazonas, Manaus, Brazil. 4 3rd Department of Internal Medicine, Aristotle University, Hypertension-24 h ambulatory blood pressure monitoring center, Papageorgiou Hospital, Thessaloniki, Greece. 5 Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy. 6 Heart, Thorax and Vascular Department, IRCCS AOU di Bologna, Bologna, Italy. 7 Department of Obstetrics and Gynecology, Clinical Hospital “Dr. Trifun Panovski”, Bitola, North Macedonia. 8 Department of Internal Medicine, Clinical Hospital “Dr. Trifun Panovski”, Bitola, North Macedonia. 9 St. Clement of Ohrid University of Bitola, Bitola, North Macedonia. 10 Department of Biomedical Engineering, Soonchunhyang University, Asan, Chungnam, Republic of Korea. 11 Department of Medicine, Solna, Karolinska Institutet. 12 Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. 13 Department of Cardiovascular Medicine and the Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA. 14 Department of Pathophysiology, Montes Claros State University, Unimontes, Montes Claros, Brazil. 15 Postgraduate Program Public Health, Federal University of Maranhão, São Luís, Brazil. 16 Geriatric Department, University Hospital of Nancy, Vandoeuvre-lés-Nancy, France. 17 FHU CARTAGE-PROFILES, Université de Lorraine, Vandoeuvre-lés-Nancy, France. 18 Department of Epidemiology, School of Public Health, Boston, Massachusetts, USA. 19 Sections of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, School of Medicine, Boston, Massachusetts, USA. 20 Boston University's and National Heart, Blood, and Lung Institute's Framingham Heart Study, Framingham, Massachusetts, USA. 21 Universidad De La Republica, Montevideo, Uruguay. 22 CUiiDARTE, Physiology Department, School of Medicine, Republic University, Montevideo, Uruguay. 23 South African Medical Research Council Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa. 24 Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. 25 Murdoch Children's Research Institute, Parkville, Melbourne, Australia. 26 Department of Paediatrics, The University of Melbourne, Parkville, Melbourne, Australia. 27 Department of General Medicine, Royal Children's Hospital, Parkville, Melbourne, Australia. 28 University of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, Brazil. 29 King's College London British Heart Foundation Centre, Department of Clinical Pharmacology, St Thomas' Hospital, London, England. 30 Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania. 31 College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 32 Department of Cardiology, Royal Children's Hospital, Parkville, Melbourne, Australia. 33 Faculty of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 34 Department of Internal Medicine, Nephrology Division, University of São Paulo, Ribeirao Preto Medical School, Ribeirão Preto, Brazil. 35 Department of Surgery Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary. 36 Department of Physiology, Faculty of Medicine, Agostinho Neto University, Luanda, Angola. 37 Department of Health Sciences at Instituto Superior Politécnico Alvorecer da Juventude (ISPAJ), Luanda, Angola. 38 University of Sherbrooke, Sherbrooke, Canada. 39 Department of Physiology, Faculty of Medicine, Katyavala Bwila University, Benguela, Angola. 40 Instituto de Investigación en Ciencias de la Salud, CONICET, CCT Tandil, Tandil, Argentina. 41 Department of Cardiology, Toulouse Rangueil University Hospital, Toulouse, France. 42 INSERM CERPOP UMR 1295, Toulouse, France. 43 Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. 44 Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. 45 Department of Medicine, University of Salamanca (USAL), Salamanca, Spain. 46 Swansea University Medical School, Swansea, UK. 47 University of Texas Health Science Center at Houston, Houston, Texas. 48 Research Unit of Biomedicine and Internal Medicine, Faculty of Medicine, University of Oulu, Medical Research Center, Oulu University Hospital, Oulu, Finland. 49 Department of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, Poznan, Poland. 50 Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 51 Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. 52 Department of Paediatrics II, Medical University of Innsbruck, Innsbruck, Austria. 53 Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea. 54 Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea. 55 Gottsegen National Cardiovascular Center, Budapest, Hungary. 56 Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. 57 Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan. 58 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. 59 Hamamatsu University School of Medicine, Hamamatsu, Japan. 60 2nd Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, Greece. 61 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA. 62 University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany. 63 University of Leipzig, LIFE Research Centre for Civilization Diseases, Leipzig, Germany. 64 School of Nursing, University of Virginia, Virgina, USA. 65 MRC Unit for Lifelong Health and Ageing, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK. 66 Clínica da Aveleira, Instituto de Investigação e Formação Cardiovascular, Coimbra, Portugal. 67 Department of Internal Medicine - Geriatric Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. 68 VASCage, Research Centre on Vascular Ageing and Stroke, Innsbruck, Austria. 69 University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. 70 Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. 71 Department of Physiological Sciences, Federal University of Espírito Santo, Brazil. 72 Hospital Universitário Cassiano Antônio Moraes, Vitória, Espírito Santo, Brazil. 73 Cardiovascular Engineering, Inc. Norwood, Massachusetts, USA. 74 Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 75 Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden. 76 Department of Social Preventive Medical Sciences, Center for Preventive Medical Sciences, Chiba University, Chiba, Japan. 77 Department of Cardiology, Chiba University Hospital, Chiba, Japan. 78 Department of Surgical, Medical Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy. 79 Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. 80 Polytechnic Institute of Coimbra, Department of Physiology, Coimbra, Portugal. 81 Laboratory for Applied Health Research (LabinSaúde), Coimbra, Portugal. 82 Harvard TH Chan School of Public Health, Boston, Massachusetts, USA. 83 Swiss Tropical and Public Health Institute, Allschwil, Switzerland. 84 University of Basel, Basel, Switzerland. 85 Emory Clinical Cardiovascular Research Institute, Emory University, Atlanta, Georgia, USA. 86 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary. 87 Dongguk University Ilsan Hospital, Goyang, Rep. of Korea. 88 College of Medicine, Dongguk University, Gyeongju, Rep. of Korea. 89 Department of Internal Medicine, Ghent University, Ghent, Belgium. 90 Hypertension Clinic, Internal Medicine, Hospital de Sagunto, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain. 91 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland. 92 Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands. 93 Division of Public Health and Epidemiology, Department of Social Medicine, Asahikawa Medical University, Asahikawa, Japan. 94 Cardiology Unit, Laboratory of Cardiovascular Research, San Luca Hospital, Milano, Italy. 95 University of Basel, Department of Sport, Exercise and Health, Sport- and Exercise Medicine, Basel, Switzerland. 96 Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Republic of Korea. 97 Institute for Biomedical Engineering and Technology, Ghent University, Ghent, Belgium. 98 Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Greece. 99 Russian Clinical and Research Center of Gerontology, Pirogov Russian National Research Medical University, Moscow, Russia. 100 Doshisha Women's college of Liberal Arts, Kyoto, Japan. 101 Department of Cardiology, Tokyo Medical University, Tokyo, Japan. 102 Preventive Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 103 School of Public Health and Department of Medicine, University of Texas Health Sciences Center, San Antonio, Texas. 104 Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts. 105 Department of Primary Care and Population Health, University College London, London, UK. Publisher Copyright: © 2023 The Author(s)
PY - 2023/6
Y1 - 2023/6
N2 - Background: Arterial stiffening is central to the vascular ageing process and a powerful predictor and cause of diverse vascular pathologies and mortality. We investigated age and sex trajectories, regional differences, and global reference values of arterial stiffness as assessed by pulse wave velocity (PWV). Methods: Measurements of brachial-ankle or carotid-femoral PWV (baPWV or cfPWV) in generally healthy participants published in three electronic databases between database inception and August 24th, 2020 were included, either as individual participant-level or summary data received from collaborators (n = 248,196) or by extraction from published reports (n = 274,629). Quality was appraised using the Joanna Briggs Instrument. Variation in PWV was estimated using mixed-effects meta-regression and Generalized Additive Models for Location, Scale, and Shape. Findings: The search yielded 8920 studies, and 167 studies with 509,743 participants from 34 countries were included. PWV depended on age, sex, and country. Global age-standardised means were 12.5 m/s (95% confidence interval: 12.1–12.8 m/s) for baPWV and 7.45 m/s (95% CI: 7.11–7.79 m/s) for cfPWV. Males had higher global levels than females of 0.77 m/s for baPWV (95% CI: 0.75–0.78 m/s) and 0.35 m/s for cfPWV (95% CI: 0.33–0.37 m/s), but sex differences in baPWV diminished with advancing age. Compared to Europe, baPWV was substantially higher in the Asian region (+1.83 m/s, P = 0.0014), whereas cfPWV was higher in the African region (+0.41 m/s, P < 0.0001) and differed more by country (highest in Poland, Russia, Iceland, France, and China; lowest in Spain, Belgium, Canada, Finland, and Argentina). High vs. other country income was associated with lower baPWV (−0.55 m/s, P = 0.048) and cfPWV (−0.41 m/s, P < 0.0001). Interpretation: China and other Asian countries featured high PWV, which by known associations with central blood pressure and pulse pressure may partly explain higher Asian risk for intracerebral haemorrhage and small vessel stroke. Reference values provided may facilitate use of PWV as a marker of vascular ageing, for prediction of vascular risk and death, and for designing future therapeutic interventions. Funding: This study was supported by the excellence initiative VASCage funded by the Austrian Research Promotion Agency, by the National Science Foundation of China, and the Science and Technology Planning Project of Hunan Province. Detailed funding information is provided as part of the Acknowledgments after the main text.
AB - Background: Arterial stiffening is central to the vascular ageing process and a powerful predictor and cause of diverse vascular pathologies and mortality. We investigated age and sex trajectories, regional differences, and global reference values of arterial stiffness as assessed by pulse wave velocity (PWV). Methods: Measurements of brachial-ankle or carotid-femoral PWV (baPWV or cfPWV) in generally healthy participants published in three electronic databases between database inception and August 24th, 2020 were included, either as individual participant-level or summary data received from collaborators (n = 248,196) or by extraction from published reports (n = 274,629). Quality was appraised using the Joanna Briggs Instrument. Variation in PWV was estimated using mixed-effects meta-regression and Generalized Additive Models for Location, Scale, and Shape. Findings: The search yielded 8920 studies, and 167 studies with 509,743 participants from 34 countries were included. PWV depended on age, sex, and country. Global age-standardised means were 12.5 m/s (95% confidence interval: 12.1–12.8 m/s) for baPWV and 7.45 m/s (95% CI: 7.11–7.79 m/s) for cfPWV. Males had higher global levels than females of 0.77 m/s for baPWV (95% CI: 0.75–0.78 m/s) and 0.35 m/s for cfPWV (95% CI: 0.33–0.37 m/s), but sex differences in baPWV diminished with advancing age. Compared to Europe, baPWV was substantially higher in the Asian region (+1.83 m/s, P = 0.0014), whereas cfPWV was higher in the African region (+0.41 m/s, P < 0.0001) and differed more by country (highest in Poland, Russia, Iceland, France, and China; lowest in Spain, Belgium, Canada, Finland, and Argentina). High vs. other country income was associated with lower baPWV (−0.55 m/s, P = 0.048) and cfPWV (−0.41 m/s, P < 0.0001). Interpretation: China and other Asian countries featured high PWV, which by known associations with central blood pressure and pulse pressure may partly explain higher Asian risk for intracerebral haemorrhage and small vessel stroke. Reference values provided may facilitate use of PWV as a marker of vascular ageing, for prediction of vascular risk and death, and for designing future therapeutic interventions. Funding: This study was supported by the excellence initiative VASCage funded by the Austrian Research Promotion Agency, by the National Science Foundation of China, and the Science and Technology Planning Project of Hunan Province. Detailed funding information is provided as part of the Acknowledgments after the main text.
KW - All-cause mortality
KW - Arterial stiffness
KW - Cardiovascular disease
KW - Hypertensive end-organ damage
KW - Prevention
KW - Pulse wave velocity
KW - Reference values
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85159848543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159848543&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2023.104619
DO - 10.1016/j.ebiom.2023.104619
M3 - Article
C2 - 37229905
AN - SCOPUS:85159848543
SN - 2352-3964
VL - 92
JO - EBioMedicine
JF - EBioMedicine
M1 - 104619
ER -